- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 12 x CS: CESIUM ION(Non-covalent)
CS.3: 3 residues within 4Å:- Chain A: Y.248, D.253
- Ligands: CL.7
No protein-ligand interaction detected (PLIP)CS.4: 2 residues within 4Å:- Chain A: L.332, G.334
No protein-ligand interaction detected (PLIP)CS.5: 4 residues within 4Å:- Chain A: R.69, K.70, S.71
- Ligands: CL.8
No protein-ligand interaction detected (PLIP)CS.6: 2 residues within 4Å:- Chain A: D.211, E.214
No protein-ligand interaction detected (PLIP)CS.14: 3 residues within 4Å:- Chain B: Y.248, D.253
- Ligands: CL.18
No protein-ligand interaction detected (PLIP)CS.15: 2 residues within 4Å:- Chain B: L.332, G.334
No protein-ligand interaction detected (PLIP)CS.16: 4 residues within 4Å:- Chain B: R.69, K.70, S.71
- Ligands: CL.19
No protein-ligand interaction detected (PLIP)CS.17: 2 residues within 4Å:- Chain B: D.211, E.214
No protein-ligand interaction detected (PLIP)CS.25: 3 residues within 4Å:- Chain C: Y.248, D.253
- Ligands: CL.29
No protein-ligand interaction detected (PLIP)CS.26: 2 residues within 4Å:- Chain C: L.332, G.334
No protein-ligand interaction detected (PLIP)CS.27: 4 residues within 4Å:- Chain C: R.69, K.70, S.71
- Ligands: CL.30
No protein-ligand interaction detected (PLIP)CS.28: 2 residues within 4Å:- Chain C: D.211, E.214
No protein-ligand interaction detected (PLIP)- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.7: 3 residues within 4Å:- Chain A: Y.248, F.249
- Ligands: CS.3
Ligand excluded by PLIPCL.8: 3 residues within 4Å:- Chain A: K.70, S.71
- Ligands: CS.5
Ligand excluded by PLIPCL.18: 3 residues within 4Å:- Chain B: Y.248, F.249
- Ligands: CS.14
Ligand excluded by PLIPCL.19: 3 residues within 4Å:- Chain B: K.70, S.71
- Ligands: CS.16
Ligand excluded by PLIPCL.29: 3 residues within 4Å:- Chain C: Y.248, F.249
- Ligands: CS.25
Ligand excluded by PLIPCL.30: 3 residues within 4Å:- Chain C: K.70, S.71
- Ligands: CS.27
Ligand excluded by PLIP- 3 x XA2: (R)-2-amino-6-borono-2-(1-(3,4-dichlorobenzyl)piperidin-4-yl)hexanoic acid(Non-covalent)
XA2.9: 18 residues within 4Å:- Chain A: H.152, D.175, H.177, D.179, N.181, A.187, S.188, H.192, G.193, D.232, D.234, D.283, D.285, T.297, E.328
- Chain C: E.79
- Ligands: MN.1, MN.2
15 PLIP interactions:14 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:N.181, A:S.188, A:D.234, A:E.328
- Water bridges: A:N.190, A:N.190, A:D.232, A:D.234, A:E.237, A:T.297, A:T.297, A:T.297
- Salt bridges: A:D.232, A:D.234
- Hydrophobic interactions: C:E.79
XA2.20: 18 residues within 4Å:- Chain A: E.79
- Chain B: H.152, D.175, H.177, D.179, N.181, A.187, S.188, H.192, G.193, D.232, D.234, D.283, D.285, T.297, E.328
- Ligands: MN.12, MN.13
19 PLIP interactions:18 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:H.152, B:N.181, B:S.188, B:D.234, B:D.283, B:D.283, B:D.283, B:T.297
- Water bridges: B:N.190, B:N.190, B:D.232, B:D.234, B:D.234, B:E.237, B:D.285, B:T.297
- Salt bridges: B:D.232, B:D.234
- Hydrophobic interactions: A:E.79
XA2.31: 18 residues within 4Å:- Chain B: E.79
- Chain C: H.152, D.175, H.177, D.179, N.181, A.187, S.188, H.192, G.193, D.232, D.234, D.283, D.285, T.297, E.328
- Ligands: MN.23, MN.24
18 PLIP interactions:17 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:H.177, C:N.181, C:S.188, C:D.234, C:D.283, C:D.283, C:D.283, C:T.297
- Water bridges: C:N.190, C:N.190, C:D.232, C:D.234, C:E.237, C:D.285, C:T.297
- Salt bridges: C:D.232, C:D.234
- Hydrophobic interactions: B:E.79
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.10: 6 residues within 4Å:- Chain A: E.97, D.100, P.101, Q.102, K.107, W.108
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.100, A:M.106, A:W.108
- Water bridges: A:R.103
GOL.11: 3 residues within 4Å:- Chain A: N.53, Y.62, E.94
1 PLIP interactions:1 interactions with chain A- Water bridges: A:R.54
GOL.21: 6 residues within 4Å:- Chain B: E.97, D.100, P.101, Q.102, K.107, W.108
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.100, B:M.106, B:W.108
- Water bridges: B:R.103
GOL.22: 3 residues within 4Å:- Chain B: N.53, Y.62, E.94
1 PLIP interactions:1 interactions with chain B- Water bridges: B:R.54
GOL.32: 6 residues within 4Å:- Chain C: E.97, D.100, P.101, Q.102, K.107, W.108
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:D.100, C:M.106, C:W.108
- Water bridges: C:R.103
GOL.33: 3 residues within 4Å:- Chain C: N.53, Y.62, E.94
1 PLIP interactions:1 interactions with chain C- Water bridges: C:R.54
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hai, Y. et al., Crystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of Schistosomiasis. Biochemistry (2014)
- Release Date
- 2014-07-16
- Peptides
- Arginase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x MN: MANGANESE (II) ION(Non-covalent)
- 12 x CS: CESIUM ION(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x XA2: (R)-2-amino-6-borono-2-(1-(3,4-dichlorobenzyl)piperidin-4-yl)hexanoic acid(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hai, Y. et al., Crystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of Schistosomiasis. Biochemistry (2014)
- Release Date
- 2014-07-16
- Peptides
- Arginase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
B